Boston Scientific Corporation (BSX)
Boston Scientific (BSX) DBS Programming Software Gets CE Mark
Boston Scientific (BSX) secures CE Mark for the DBS image-guided programming software, Vercise Neural Navigator 5.
3 Record-Breaking Stocks With More Room to Run
U.S. markets continued to set all-time highs in June, with record-breaking stocks boosting major indices to new records last week. Even the traditionally slower DJIA logged two consecutive record peaks in two days.
Why Boston Scientific (BSX) Dipped More Than Broader Market Today
Boston Scientific (BSX) closed the most recent trading day at $76.71, moving -1.29% from the previous trading session.
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Boston Scientific (BSX) to Buy Silk Road, Boost Cardiology
This acquisition is expected to enhance Boston Scientific's (BSX) market position and revenue streams in North America and Europe.
4 Medical Product Stocks to Buy From a Recovering Industry
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. BSX, RMD, LNTH and HAE are well-poised to gain from the favorable factors.
Boston Scientific (BSX) Rises Yet Lags Behind Market: Some Facts Worth Knowing
The latest trading day saw Boston Scientific (BSX) settling at $76.31, representing a +0.16% change from its previous close.
Boston Scientific Buys Silk Road Medical for $1.26 Billion
Shares of Silk Road Medical (SILK) soared in intraday trading Tuesday after Boston Scientific (BSX) announced it was buying the medical device maker for about $1.26 billion.
Boston Scientific Adds Stroke Prevention To Vascular Portfolio Via Silk Road Medical's $1.3B Deal
Tuesday, Boston Scientific Corporation BSX agreed to acquire Silk Road Medical Inc SILK for $27.50 in cash per share, representing an equity value of approximately $1.26 billion.
Silk Road Medical Stock Soars. It's Being Acquired by Boston Scientific.
Boston Scientific will pay $27.50 a share, or $1.16 billion, for Silk Road Medical.
Boston Scientific to buy Silk Road Medical in $1.16 billion deal
Boston Scientific will acquire medical device maker Silk Road Medical in a $1.16 billion deal, the companies said on Tuesday.
Boston Scientific (BSX) Ascends But Remains Behind Market: Some Facts to Note
In the most recent trading session, Boston Scientific (BSX) closed at $77.41, indicating a +0.34% shift from the previous trading day.
